Last June, the government commissioned the Advisory Council on the Misuse of Drugs to review the harms and consider control of 2-methyl-AP-237 and other closely related acyl piperazine opioids. The ACMD has now issued its report.
Last June, the government commissioned the Advisory Council on the Misuse of Drugs to review the harms and consider control of 2-methyl-AP-237 and other closely related acyl piperazine opioids. The ACMD has now issued its report.